KNIT Enables Safer CAR-T Manufacturing Without DNA Double-Strand Breaks

CRISPR-Cas9 serves as the ultimate "Swiss Army knife" of genome editing, yet it suffers from a fundamental flaw: it cleaves both strands of the DNA double helix. While double-strand breaks (DSBs) efficiently trigger repair mechanisms, they also unleash a cascade of adverse side effects, including insertion-deletion mutations (indels), chromosomal translocations, large genomic deletions, and off-target cleavage. While such unintended genomic events might be tolerable in basic research, they pose severe safety hazards in human gene and cell therapies.

This raises a pivotal question: Can we achieve high-efficiency knock-in by cleaving only a single strand? Theoretically, a single-strand nick is far safer than a DSB—it refrains from causing indels or chromosomal translocations. However, nickase-mediated homology-directed repair (HDR) historically suffers from abysmal efficiency, keeping the strategy trapped at the conceptual stage for years.

Recently, researchers from Tsinghua University published a groundbreaking study in Nature titled "Efficient and precise programmable DNA knock-in without double-strand breaks." Led by Dr. Haifeng Wang's laboratory, the study breaks through this long-standing bottleneck with a novel technology called the KNIT editing platform.

The underlying logic of KNIT (CRISPR Kilobase Nickase-Targeted Editing) is elegantly simple yet ingenious: since a Cas9 nickase (which cuts only one DNA strand) is intrinsically poor at recruiting donor DNA, why not equip it with a "donor recruitment system"? By enriching DNA donor templates directly at the target locus, KNIT dramatically boosts HDR efficiency.

KE1 (First Generation): Achieved precise knock-in of large DNA fragments exceeding 10 kilobases (kb), far outperforming conventional nickase systems.

KE2 (Second Generation): Further optimized donor enrichment at target sites, pushing knock-in efficiencies up to an extraordinary 89%.

Profound Safety Advantages

Compared with classical Cas9 tools, KNIT exhibits extremely low indel rates and dramatically reduced levels of chromosomal translocations. Crucially, because it avoids generating indels, unedited or partially edited cells can undergo repeated rounds of re-editing—a feature impossible in traditional DSB-based systems, where initial editing scars (indels) disrupt subsequent gRNA recognition.

CAR-T Engineering: Virus-Free and DSB-Free

The research team demonstrated precise integration of CAR constructs into the clinically pivotal TRAC locus, achieving an average knock-in efficiency of 32.9% and peaking at 40.6%. The entire process requires neither viral vectors nor the induction of double-strand breaks. The resulting CAR-T cells maintained robust proliferative capacity and exhibited potent antitumor activity in both in vitro tumor cytotoxicity assays and tumor-bearing mouse models.

Therapeutic Correction of Genetic Disorders

In disease-model cells harboring pathogenic mutations in the LIPA gene (a model for lysosomal acid lipase deficiency), KNIT precisely integrated wild-type LIPA cDNA into the AAVS1 safe-harbor locus, successfully restoring both LIPA RNA and protein expression.

Figure 1. KNIT editing: single nick-based programmable kilobase-scale DNA insertion. (Gao Y, et al., 2026)

Broad Significance and Future Outlook

The KNIT editing platform represents a fundamental paradigm shift: moving from "violent shearing" to "gentle nicking," and transitioning from "one-shot editing with permanent scars" to "repeatable editing with zero footprint."

For CAR-T cell immunotherapy, a non-viral, DSB-free engineering pipeline translates into diminished oncogenic risks and enhanced manufacturing consistency. For human gene therapy targeting inherited diseases, the combination of an 89% knock-in efficiency and safe-harbor locus targeting transforms "repairing rather than disrupting" into a tangible clinical reality. KNIT stands poised as one of the most critical technological platforms in genome engineering since the advent of CRISPR-Cas9.